RAC 0.60% $1.69 race oncology ltd

Ann: Compelling Preclinical Breast Cancer Results, page-187

  1. 8,519 Posts.
    lightbulb Created with Sketch. 1398
    The "next steps" section of the announcement says explicitly that breast cancer FTO is one of the next steps.

    I agree that it makes sense to complete that before starting either of the two FTO studies already announced.

    Because the FTO pillar is binary; bisantrene is either effective in all FTO-overexpressed cancers or in none of them.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.